Ignite Creation Date:
2025-12-24 @ 12:01 PM
Ignite Modification Date:
2026-02-25 @ 9:45 PM
Study NCT ID:
NCT03923361
Status:
WITHDRAWN
Last Update Posted:
2019-12-18
First Post:
2019-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neural and Antidepressant Effects of Propofol (Phase 2)
Sponsor:
University of Utah
Organization:
Study Overview
Official Title:
Neural and Antidepressant Effects of Propofol (Phase 2)
Status:
WITHDRAWN
Status Verified Date:
2019-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Change in study design based on phase 1 data collection; patient burden was not feasible
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Moderate-intensity propofol treatments will be administered to participants who are non-responders at the end of Phase 1.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: